HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free Supplemental Data All Versions of this Article: fj.07-100966v1 22/8/3010    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dallabrida, S. M. Articles by Rupnick, M. A. Search for Related Content PubMed PubMed Citation Articles by Dallabrida, S. M. Articles by Rupnick, M. A.

Integrin binding angiopoietin-1 monomers reduce cardiac hypertrophy

Susan M. Dallabrida^*,, Nesreen S. Ismail^*, Elke A. Pravda^*, Emily M. Parodi^*, Renee Dickie, Ellen M. Durand^*, Jean Lai, Flavia Cassiola^*, Rick A. Rogers^*, and Maria A. Rupnick^1,*,,,¶

^* Division of Vascular Biology, Children’s Hospital, Boston, Massachusetts, USA;

Harvard Medical School Affiliates, Boston, Massachusetts, USA;

Harvard School of Public Health, Harvard University, Boston, Massachusetts, USA;

Chemical Engineering Department, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA; and

^¶ Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA

¹Correspondence: Children’s Hospital, Vascular Biology Division, 1 Blackfan Cir., Karp Bldg. RB 11–211, Boston, MA 02115, USA. E-mail: maria.rupnick{at}childrens.harvard.edu

Angiopoietins were thought to be endothelial cell-specific via the tie2 receptor. We showed that angiopoietin-1 (ang1) also interacts with integrins on cardiac myocytes (CMs) to increase survival. Because ang1 monomers bind and activate integrins (not tie2), we determined their function in vivo. We examined monomer and multimer expressions during physiological and pathological cardiac remodeling and overexpressed ang1 monomers in phenylephrine-induced cardiac hypertrophy. Cardiac ang1 levels (mRNA, protein) increased during postnatal development and decreased with phenylephrine-induced cardiac hypertrophy, whereas tie2 phosphorylations were unchanged. We found that most or all of the changes during cardiac remodeling were in monomers, offering an explanation for unchanged tie2 activity. Heart tissue contains abundant ang1 monomers and few multimers (Western blotting). We generated plasmids that produce ang1 monomers (ang1–256), injected them into mice, and confirmed cardiac expression (immunohistochemistry, RT-PCR). Ang1 monomers localize to CMs, smooth muscle cells, and endothelial cells. In phenylephrine-induced cardiac hypertrophy, ang1–256 reduced left ventricle (LV)/tibia ratios, fetal gene expressions (atrial and brain natriuretic peptides, skeletal actin, β-myosin heavy chain), and fibrosis (collagen III), and increased LV prosurvival signaling (akt, MAPK_p42/44), and AMPK_T172. However, tie2 phosphorylations were unchanged. Ang1–256 increased integrin-linked kinase, a key regulator of integrin signaling and cardiac health. Collectively, these results suggest a role for ang1 monomers in cardiac remodeling.—Dallabrida, S. M., Ismail, N. S., Pravda, E. A., Parodi, E. M., Dickie, R., Durand, E. M., Lai, J., Cassiola, F., Rogers, R. A., Rupnick, M. A. Integrin binding angiopoietin-1 monomers reduce cardiac hypertrophy.

Key Words: cardiac myocytes • endothelial cells • integrin-linked kinase • AMP-activated protein kinase • Tie2

This article has been cited by other articles:

				H. T. Yuan, E. V. Khankin, S. A. Karumanchi, and S. M. Parikh Angiopoietin 2 Is a Partial Agonist/Antagonist of Tie2 Signaling in the Endothelium Mol. Cell. Biol., April 15, 2009; 29(8): 2011 - 2022. [Abstract] [Full Text] [PDF]

				J.-X. Chen and A. Stinnett Ang-1 Gene Therapy Inhibits Hypoxia-Inducible Factor-1{alpha} (HIF-1{alpha})-Prolyl-4-Hydroxylase-2, Stabilizes HIF-1{alpha} Expression, and Normalizes Immature Vasculature in db/db Mice Diabetes, December 1, 2008; 57(12): 3335 - 3343. [Abstract] [Full Text] [PDF]